Bursky Annual Symposium

Each year the Bursky Center hosts an annual symposium which profiles advances in the field of human immunology.

Third Annual Symposium

Thursday, March 7, 2019
Eric P. Newman Education Center, Auditorium
Washington University, School of Medicine

The symposium will feature distinguished scientists and profile remarkable advances in the development of treatment options for cancer, infectious diseases, autoimmune disorders, and brain tumors.  The following list highlights featured talks:

"Immune Checkpoint Blockade in Cancer Therapy: Historical Perspective, New Insights, and Prospects for Cures"
James P. Allison, PhD
Professor and Chair, Department of Immunology
University of Texas, MD Anderson Cancer Center
Nobel Prize in Physiology or Medicine 2018

"ILC Recognition of Tumor Cells"
Marco Colonna, MD
Robert Rock Belliveau MD Professor, Pathology & Immunology

"Human Tuberculosis: A moving target"
Shabaana Khader, PhD
Professor and Interim Chair, Molecular Microbiology

"Genetic Variants in Complement Regulators Causing Human Disease"
John P. Atkinson, MD
Samuel B. Grant Professor, Medicine, Division of Rheumatology
Professor, Molecular Microbiology


Second Annual Symposium Highlights

On Tuesday, February 27, 2018, the second annual symposium was held.  The symposium featured distinguished scientists and profiled remarkable advances in the development of treatment options for cancer, infectious diseases, autoimmune disorders, and brain tumors.  The following list highlights featured talks:

"Impressions of the New NCI Director"
Norman E. "Ned" Sharpless, MD
Director, National Cancer Institute

"Things I Learned at Washington University and Industry about Drug Discovery and Development"
Philip Needleman, PhD
Professor & Chair Emeritus, Department of Pharmacology

"Leveraging Neoantigen Discovery in Glioblastoma"
Gavin Dunn, MD, PhD
Assistant Professor of Neurological Surgery, Pathology & Immunology

Bursky Scholar

"One in a Billion: Diagnosis and Treatment of Rare Pediatric Immune Diseases"
Megan Cooper, MD, PhD
Assistant Professor of Pediatrics, Pathology & Immunology

"From Autoimmunity to Zika: Understanding Links between Cell-Intrinsic Innate Immunity, Viruses and Autoimmunity"
Jonathan Miner, MD, PhD
Assistant Professor of Medicine, Molecular Microbiology, Pathology & Immunology


Inaugural Symposium Highlights

On Thursday, February 2, 2017, the inaugural symposium was held.  The symposium featured distinguished scientists and profiled remarkable advances in the development of treatment options for cancer, infectious diseases, autoimmune disorders, and brain tumors.  The following list highlights featured talks:

"Advances in Personalized Cancer Immunotherapy"
Robert D. Schreiber, PhD
Andrew M. and Jane M. Bursky Distinguished Professor
Director, Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs

"New Insights into Human Diseases Caused by Immune System Dysfunction"
Wayne M. Yokoyama, MD
Sam J. Levin and Audrey Lowe Levin Professor of Arthritis Research
Associate Director, Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs

"Discoveries in Basic Biology of Infectious Diseases and Their Rapid Transition to Drug and Vaccine"
Michael S. Diamond, MD, PhD
Herbert S. Gasser Professor
Associate Director, Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs

"Innovation, Crisis and the Role of Biotechnology"
Robert I. Tepper, MD
Partner and Co-Founder, Third Rock Ventures, LLC

"Building Better Medicines: The Role of the Biopharmaceutical Industry"
Roger M. Perlmutter, MD, PhD
Executive Vice President, Merck & Co.
President, Merck Research Laboratories